tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MGTX Stock Latest News

MeiraGTx Reports Progress in Genetic Medicines Development
Company AnnouncementsMeiraGTx Reports Progress in Genetic Medicines Development
14d ago
MGTX
MeiraGTx reports Q2 EPS (48c) vs (76c) last year
PremiumThe Fly
MeiraGTx reports Q2 EPS (48c) vs (76c) last year
15d ago
MGTX
Vinay Prasad returns to FDA as head of CBER
PremiumThe Fly
Vinay Prasad returns to FDA as head of CBER
20d ago
CAPR
MGTX
Navigating AI Challenges: Meiragtx Holdings’ Battle with Operational Risks and Compliance
PremiumCompany Announcements
Navigating AI Challenges: Meiragtx Holdings’ Battle with Operational Risks and Compliance
1M ago
MGTX
MeiraGTx Gains UK Approval for Hologen Transactions
PremiumCompany Announcements
MeiraGTx Gains UK Approval for Hologen Transactions
2M ago
8K
MGTX
MeiraGTx initiated with a Buy at Lucid Capital
PremiumThe FlyMeiraGTx initiated with a Buy at Lucid Capital
3M ago
MGTX
MeiraGTx Reports Q1 2025 Results and Strategic Advances
Premium
Company Announcements
MeiraGTx Reports Q1 2025 Results and Strategic Advances
4M ago
MGTX
MeiraGTx reports Q1 EPS (51c) vs. (32c) last year
Premium
The Fly
MeiraGTx reports Q1 EPS (51c) vs. (32c) last year
4M ago
MGTX
MeiraGTx Holdings Receives FDA RMAT Designation for AAV-GAD
PremiumCompany Announcements
MeiraGTx Holdings Receives FDA RMAT Designation for AAV-GAD
4M ago
8K
MGTX
MeiraGTx announces FDA granted RMAT designation to AAV-GAD
PremiumThe Fly
MeiraGTx announces FDA granted RMAT designation to AAV-GAD
4M ago
MGTX
Controversial doctor Vinay Prasad named CBER director, STAT reports
PremiumThe Fly
Controversial doctor Vinay Prasad named CBER director, STAT reports
4M ago
DYN
RNA
Buy Rating for Meiragtx Holdings: Promising Secondary Endpoint Results and Regulatory Optimism Drive Confidence
PremiumRatings
Buy Rating for Meiragtx Holdings: Promising Secondary Endpoint Results and Regulatory Optimism Drive Confidence
4M ago
MGTX
RBC sees Makary interview as potentially positive for biotech stocks
PremiumThe FlyRBC sees Makary interview as potentially positive for biotech stocks
4M ago
DYN
RNA
MeiraGTx Holdings Signs New Lease in New York
Premium
Company Announcements
MeiraGTx Holdings Signs New Lease in New York
5M ago
8K
MGTX
MeiraGTx Reports Strategic Advances and Financial Results
Premium
Company Announcements
MeiraGTx Reports Strategic Advances and Financial Results
5M ago
MGTX
Biotech stocks slide as Marks resignation seen being negative for sector
PremiumThe Fly
Biotech stocks slide as Marks resignation seen being negative for sector
5M ago
DYN
MGX
Marks resignation ‘not good’ for biotech sector, says RBC
PremiumThe Fly
Marks resignation ‘not good’ for biotech sector, says RBC
5M ago
DYN
RNA
MeiraGTx price target raised to $13 from $11 at RBC Capital
PremiumThe Fly
MeiraGTx price target raised to $13 from $11 at RBC Capital
6M ago
MGTX
MeiraGTx price target raised to $14 from $12 at BofA
PremiumThe Fly
MeiraGTx price target raised to $14 from $12 at BofA
6M ago
MGTX
MeiraGTx Holdings Faces Financial Uncertainty Over Priority Review Vouchers for Gene Therapy
PremiumCompany AnnouncementsMeiraGTx Holdings Faces Financial Uncertainty Over Priority Review Vouchers for Gene Therapy
6M ago
MGTX
MeiraGTx Holdings Announces Joint Venture with Hologen
Premium
Company Announcements
MeiraGTx Holdings Announces Joint Venture with Hologen
6M ago
8K
MGTX
MeiraGTx reports FY24 EPS ($2.12) vs ($1.49) last year
Premium
The Fly
MeiraGTx reports FY24 EPS ($2.12) vs ($1.49) last year
6M ago
MGTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >